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Tonsil caseous affects a significant percentage of the 
population. Surgeries, conservative or not, have been the only 
viable alternatives of treatment. However, today there is still 
not, up to now, an economical and non-invasive treatment 
that presents satisfactory results. Aims: The objectives of this 
study are to evaluate the efficiency of a mouthwash, with 
active ingredients that associate oxygenating and antimicrobial 
substances, in the reduction of caseous and tongue coating 
formation, whose etiology is similar to caseous, and to 
evaluate the reduction of the volatile sulfur compounds 
(VSCs) concentration. Study design: Double blind, placebo-
controlled, randomized, clinical and experimental study. 
Material e methods: A sample of 50 volunteers with more 
than one year of chronic caseous tonsillitis complaint used it. 
The research was carried out in 2005, in the cities of São Paulo 
and Campinas. Results: For the group that used the placebo 
solution, there was no correlation between the variables or 
statistical significance in the results. For the group that used 
the mouthwash, the results were significant in all analyzed 
questions. Conclusions: This new mouthwash proved to be 
a viable conservative alternative for the treatment of tonsil 
caseous, being also efficient in the reduction of tongue 
coating formation and VSCs concentration.
Keywords: mouthwashes, sulfur compounds, halitosis, tongue, 
double-blind method, tonsils.
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INTRODUCTION
Caseum can build up in the pharyngeal tonsils’ ca-
vities or crypts (Figure 1), basically, it happens when there 
is salivary flow reduction or epithelial shedding above the 
physiological limits, or both occurring simultaneously1. It is 
a yellowish viscous and smelly mass, than can be expelled 
during speech, cough or sneezes. Its name derives from 
the Latin word “caseum”, which means cheese, because 
it is similar to a small “cheese ball”.
gastritis, pneumonia and periodontal disease, the latter is 
also associated with many other systemic disorders1.
The clinical treatment5 proposed for tonsil caseum 
so far involve the use of anti-inflammatory agents, gargling 
substances with saline and antiseptic solutions, without 
satisfactory results; or the surgical treatment by means of 
radical or conventional tonsillectomies6,7, or even laser-as-
sisted surgery8-11. The valid surgical option to treat tonsil ca-
seum has been laser-assisted cryptolisis4,12, which is based 
on removing parts of the crypts, though preserving part of 
the pharyngeal tonsils. The problems this method presents 
are, depending on the technique used, due to volatilization 
or coagulation, a painful postoperative recovery, the fact 
that many surgical interventions may be required and its 
cost, which is still high, especially in Brazil. 
Recognizing pharyngeal tonsils as a lymphoepi-
thelial organ with an important immune function13-15 and 
for that, in principle, must be preserved, led us to try and 
find a conservative method to inhibit the formation of 
caseum and, consequently, keep the pharyngeal tonsils. 
The literature findings on mouth rinsing substances in 
the prevention of caseum formation are insignificant. An 
inverse situation happens with tongue saburra, which has 
considerable literature on which substances have a positive 
effect on its formation1,16,17. Tongue saburra is made up just 
like caseum1. Thus, hypothetically the substances that act 
on the lingual saburra could have a positive effect, also on 
tonsil caseum. Therefore, the use of a mouthwash, which 
is the goal of the present investigation, specifically deve-
loped for this purpose, would mean an important option 
for conservative treatment of tonsil caseum. 
This new mouthwash was patented by the Halitus® 
company, together with Propeq, a junior company from 
the school of chemical engineering of the State University 
of Campinas - Unicamp, taking into account the legislation 
in effect from the National Agency of Sanitary Surveillance 
(ANVISA), as well as all the recommendations from the 
Food and Drug Administration (FDA) and the many phar-
macopoeias from many countries. 
The goals of the present investigation are to assess 
the efficacy of this new mouthwash in reducing the for-
mation of tonsil caseum and tongue saburra - with similar 
etiology to that of the caseum; and to asses the reduction 
in volatile sulphur compounds (VSCs) concentration.
MATERIALS AND METHODS
The study was designed o be a contemporary lon-
gitudinal cohort; clinical and experimental, randomized 
and double blind, placebo controlled. 
This study involved the participation of human 
beings, and it was approved under protocol number 
05/291, issued on July 20, 2005 by the Ethics in Research 
Committee of the School of Dentistry of São Leopoldo/ 
Mandic.
Figure 1. Caseum inside a tonsil crypt.
It is made up of epithelial cells that shed off the 
oral mucosa, salivary proteins and protein remains of food, 
that will serve as food stuff to the proteolytic anaerobe 
bacteria that dwell there.1 Bacterial metabolism produce a 
foul smelling compound at the end, called Volatile Sulphur 
Compounds (VSC) - sulfur-derived gases. These gases, as 
they reach a certain concentration, give the breath a cha-
racteristic smell of sulfur or that of a rotten egg, making 
up a common etiology for chronic halitosis2,3.
Tonsillitis or caseous chronic tonsillitis have its signs 
and symptoms reported as a feeling of frequent throat 
discomfort or irritation, and is characterized by shedding 
tonsil caseum alone or associated with other symptoms 
such as halitosis, feeling of foreign body or repetition ton-
sillitis. Such symptoms may still be followed of hyperemia 
and pharyngeal tonsil hypertrophy, without fever, and 
usually disappear after the caseum is shed. This disorder 
can happen at any age, especially in individuals who have 
never had tonsil symptoms4.
Controlling tonsil caseum is an important tool to 
prevent diseases, because the bacteria present in this 
process (practically the same in the tongue saburra) are 
associated with the etiology of some diseases such as 
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The voluntaries were submitted to screening and 
selected based on the following inclusion criteria: a com-
plaint of chronic caseous tonsillitis for more than one 
year, having caseous shedding as the main symptom and 
caseous shedding alone or followed by other symptoms 
such as halitosis, a feeling of foreign body and/or acute 
tonsillitis. We used a sample made of healthy adults, of 
any gender, older than 18 years of life and non-users of 
illicit drugs. 
Each volunteer was assessed three times: initial 
evaluation, after four weeks and final evaluation - 8 weeks 
after the study began, in three items:
1) Frequency of shedding caseum;
2) Halitometry - in order to check for VSC in parts 
per billion (PPB) by making use of a Halimeter® RH 17;
3) Tongue saburra volume (a 0 to 5 scale, advocated 
by the author):
0 - No saburra;
1 - Mild saburra present in the tongue’s posterior 
third;
2 - Mild saburra present in the medium and posterior 
thirds of the tongue;
3 - Moderate saburra in the posterior third of the 
tongue;
4 - Moderate saburra in the medium and posterior 
thirds of the tongue;
5 - Moderate saburra in the anterior, medium and 
posterior thirds of the tongue. 
Observation: a) Mild saburra: the lingual papillas are 
visible, despite the tongue saburra; b) Moderate saburra: 
lingual papillas are not visible, and are covered by the 
tongue saburra. 
The volunteers were informed of the objective of 
this study and signed an informed consent form.
The volunteers were called by the publication of 
notes about the research in popular newspapers of large 
circulation. We needed two adds to reach a total of 62 
volunteers. Of these, 31 used flasks with the placebo so-
lution and 31 used the mouthwash.
 
Composition:
Placebo: demineralized water, dye, essence and 
edulcorant;
Mouthwash: demineralized water, dye, and essence, 
edulcorant, fluorine, preservative, solubilizer, hydrogen pe-
roxide, sodium perborate and cetylpyridinium chloride.
The different solutions were randomly given to the 
volunteers, by order of service in the initial evaluation, with 
the letters A and B for the different groups, for a first group 
of volunteers, and letters C and D for the second group. 
This second group joined the study some weeks after the 
first group, because it was difficult to find volunteers after 
only one add campaign.
Mode of use: the subjects were asked to gargle 5 
ml of the solution for 20 seconds every 12 hours (morning 
and night), followed by mouthing the same solution for 
20 seconds. After that the volunteers were instructed to 
spit the entire solution and not to drink, eat or wash their 
mouths for at least 20 minutes. Moreover, each volunteer 
was instructed as to keep using the product, not miss any 
of the sessions and keep the same oral hygiene routine 
they had been following before the study so as to prevent 
any alteration from impacting the frequency at which ca-
seum appeared in the oral cavity, VSC concentration and 
tongue saburra quantity.
At the end of the study, 12 of these volunteers were 
excluded for the following reasons: they abandoned the 
study or did not come to one of the sessions for personal 
reasons or on account of disease, and also for having 
temporarily interrupted the use of the product. 
The average volunteer age as 40 years. Users of 
fixed, partial and removable dental prosthesis were 24%; 
and 4% wore orthodontic braces. Their gums were consi-
dered good in 70% of the cases; while 30% had gingivitis; 
20% had mild gingivitis, sporadic gum bleeding when 
hey flossed and 10% with moderate gingivitis, with gum 
bleeding at least twice a week, with dental floss and /or 
tooth brush.
The information about caseum shedding, as well 
as VSC readings and tongue saburra levels were noted in 
the volunteers’ charts and they also signed the charts in 
order to authenticate the truthfulness of the information 
collected.
Their tongues were photographed in each session. 
Using a 5.1 Mega pixels Nikon Coolpix 5200 digital camera, 
for comparative analysis of the tongue appearances.
Halitometry - to check for VSC concentrations - in 
parts per billion (ppb) - we used a Halimeter® RH 17, for 
these measures (Figure 2).
Figure 2. Halimeter® RH 17.
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RESULTS
The average results from the group that used the 
placebo solution (Table 1) showed that a slight reduction 
in the formation of tonsil caseum and in the ppb concen-
tration of VSC and a slight increase in the level of tongue 
saburra.
For the t-Student test, carried out in the initial and 
final variables, to check the statistical significance of the 
group that used the placebo solution (Table 2), there was 
no significance among the samples.
As we checked the statistical correlation among the 
variables from the group that used the placebo solution 
(Table 3) we did not see any correlation among them. 
For the mean values of the results from the group 
that used the mouthwash (Table 4), there was a significant 
reduction in the tonsils caseum in the ppb concentration 
of VSCs and in the level of tongue saburra.
For the t-Student test carried out in the initial and 
final variables, in order to check the statistical significance 
of the group that used the mouthwash (Table 5), there 
was statistical significance among the samples at the level 
of 1% (alpha = 0.01) in all the variables. 
As we checked the statistical correlation among the 
variables (Table 6) from the group that used the mou-
thwash, there was a correlation at the level of 1% (alpha = 
0.01), for the variables Halitometry - ppb of VSCs X level 
of tongue saburra (from 0 to 5) (r = 0.6535).
Table 1. Results from the group that used the placebo solution.
Number of the vo-
lunteer
Frequency of caseum at every 04 weeks
Halitometry
- VSC in PPB
Level of tongue saburra
 (from 0 to 5)
Initial Final Initial Final Initial Final
1. 4 4 171 180 2 2
2. 1 0 151 26 2 2
3. 4 4 102 131 1 2
4. 1 10 54 35 0 1
5. 2 4 54 18 1 1
6. 4 4 155 79 1 1
7. 3 2 182 332 3 3
8. 4 3 151 20 2 1
9. 1 0 95 308 1 2
10. 2 2 156 127 3 1
11. 2 0 35 20 1 2
12. 4 1 514 49 2 1
13. 2 0 169 63 1 3
14. 4 1 84 75 1 1
15. 3 1 50 41 1 1
16. 2 0 46 39 1 1
17. 4 2 56 183 1 3
18. 8 1 180 116 1 1
19. 2 0 58 364 3 2
20. 1 1 123 96 1 1
21. 4 3 37 40 1 1
22. 3 3 72 76 1 2
23. 6 6 221 220 1 1
24. 4 0 46 59 3 1
25. 2 1 29 55 1 1
MEAN 3,08 2,12 119,64 110,08 1,44 1,52
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Table 2. T-Student test carried out in the INITIAL and FINAL variables to check the statistical significance of the group that used the placebo 
solution.
Variable t-Student Significance
Frequency of caseum at every 04 weeks 1,78 Not significant, equal samples, alpha > 0.05.
Halitometry VSC in ppb 0,35 Not significant, equal samples, alpha > 0.05.
Intensity of tongue saburra (from 0 to 5) 0,40 Not significant, equal samples, alpha > 0.05.
Table 3. Pearson’s correlation test applied to the variables after calculating the INITIAL data minus the FINAL at the end of treatment for the 
group that used the placebo solution. 
Variables r Correlation
Caseum frequency at every 04 weeks  X Halitometry - VSC ppb 0,0695 There is no correlation among the variables
Caseum frequency at every 04 weeks X Intensity of tongue saburra (from 0 to 5) 0,2155 There is no correlation among the variables
Halitometry - VSC ppb  X Intensity of tongue saburra (from 0 to 5) 0,1815 There is no correlation among the variables
Table 4. Results from the group that used the mouthwash
Number of the volun-
teer
Frequency of caseum at every 04 weeks
Halitometry
- VSC in PPB
Level of tongue saburra
 (from 0 to 5)
Initial Final Initial Final Initial Final
26. 2 0 329 40 3 2
27. 3 1 54 58 1 1
28. 2 0 94 29 1 0
29. 2 0 296 62 3 1
30. 3 0 483 10 3 1
31. 2 0 35 15 1 1
32. 10 4 65 43 0 1
33. 4 2 414 133 4 2
34. 2 0 158 50 2 1
35. 12 2 212 48 1 1
36. 4 2 57 18 1 1
37. 8 2 139 53 2 1
38. 30 4 194 38 1 1
39. 2 1 55 20 3 1
40. 2 0 33 24 1 0
41. 8 1 55 42 1 1
42. 4 1 75 81 1 1
43. 2 0 18 75 2 2
44. 2 0 327 38 3 1
45. 3 0 40 17 1 1
46. 3 1 96 10 1 0
47. 2 1 75 08 1 1
48. 2 0 78 30 1 1
49. 2 1 65 19 1 1
50. 3 0 92 43 2 1
MEAN 4,76 0,92 141,56 40,16 1,64 1
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DISCUSSION
For more than eight years treating patients with 
bad breath, we have seen many different methods and 
products have been used to reduce or even interrupt the 
formation of tonsil caseum, which is a problem that affects 
a significant portion of the population, especially those 
with halitosis. 
As we surveyed the literature looking for conserva-
tive treatment options for pharyngeal tonsil caseum, we 
noticed that there is no non-invasive and low cost treat-
ment method available today4,12. Laser cryptolysis is the 
only conservative method so far that offers good results, 
however it is costly and, depending on the technique em-
ployed - by volatilization or coagulation, it is painful in the 
post-op and often times requires many procedures. 
Thus, based on the assumption that pharyngeal 
tonsil caseum etiology and mechanism of formation are the 
same as those of tongue saburra1, a hypothesis was formed 
that some substances that have proven effect on controlling 
tongue saburra could also act on tonsil caseum. Tests with 
different concentrations and formulations were carried out 
and some substances indeed had a positive effect in redu-
cing caseum. When it worked, the substance was patented 
and, together with the State University of Campinas, the 
mouthwash was developed within excellence technical 
and scientific parameters. After that we followed it with a 
long stage of clinical tests in order to reach the formulation 
that would yield the best clinical results. 
The products used for gargling and mouth washing 
usually have alcohol in their formulation, and this dries 
and dehydrates the oral mucosa, increasing cell shedding 
and, consequently, increasing tongue saburra and tonsil 
caseum. It happens because of proteolytic bacteria that 
degrade these scaled cells, which are protein remains that 
cause VSCs1 in this process. Thus, an important characte-
ristic of this mouthwash we developed is that is does not 
have alcohol in its formula.
Another important characteristic of this mouthwash 
is the presence of oxygenators (one or more associated), 
which will act inhibiting the formation of caseum becau-
se they periodically oxygenate the tonsil crypts, making 
them less prone to anaerobic bacterial colonizing, and 
antimicrobial agents (one or more in association), in 
order to reduce the bacteria population present in the 
caseum forming sites. There are many studies showing 
that Hydrogen Peroxide1,18,19, Sodium Perborate20 and Ce-
tylpyridinium Chloride1,21-24 - active components used in 
the mouthwash formula, are a safe and efficient alternative 
in the treatment and prevention of gingivitis; and Cetyl-
pyridinium Chloride is an effective anti-septic agent for 
oropharyngeal disorders25. Therefore, this new mouthwash 
could be recommended for patients with pharyngeal tonsil 
caseum, and also aid in the treatment of halitosis, because 
its components act on 3 of the main causes of oral-born 
halitosis: tongue saburra, gingivitis and tonsil caseum. 
One factor that must be analyzed in the results ob-
tained by the placebo solution in reducing tonsil caseum is 
probably due to the liquid turbulence caused by gargling 
twice a day. One hypothesis to be investigated for these 
results is that, those crypts more anatomically accessible 
by gargling may respond positively to the reduction in the 
formation of tonsil caseum, probably due to the cleaning 
action of gargling itself with the placebo solution inside 
the crypts. 
CONCLUSIONS
For the results presented by the group that used the 
placebo solution, there was neither statistically significant 
Table 5. T-Student test carried out in the INITIAL and FINAL variables to check the statistical significance of the group that used the mouthwa-
sh.
Variables t-Student Significance
Caseum frequency at every 04 weeks 3,78 Significante ao nível de 1% (alfa = 0,01).
VSC ppb from the halitometry 4,09 Significante ao nível de 1% (alfa = 0,01).
Intensity of tongue saburra (from 0 to 5) 3,72 Significante ao nível de 1% (alfa = 0,01).
Table 6. Pearson’s correlation test applied to the variables after calculating the INITIAL data minus the FINAL from the treatment of the group 
that used the mouthwash.
Variables r Correlation
Caseum frequency at every 04 weeks 0,0847 There is no correlation among the variables
VSC ppb from the halitometry -0,2712 There is no correlation among the variables
Intensity of tongue saburra (from 0 to 5) 0,6535
There is correlation at the level of 1%
(Alpha = 0.01)..
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result nor variable correlation.
For the group that used the mouthwash solution, all 
results were statistically significant, and there was a cor-
relation between VSC ppb - halitometry x level of tongue 
saburra, at the level of 1% (alpha = 0.01).
The mouthwash, when compared to placebo, yiel-
ded better results in all items analyzed, proving to be a 
feasible conservative alternative to treat caseous chronic 
tonsillitis, being also efficient in reducing VSC and tongue 
saburra. 
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